{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:50:35Z","timestamp":1784929835545,"version":"3.55.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>This study investigated whether the age, creatinine, and ejection fraction (ACEF) score [age (years) \/ejection fraction (%) +1 (if creatinine&gt;176\u03bcmol\/L)] could predict 1-year outcomes following ST-segment elevation myocardial infarction after percutaneous coronary intervention, and whether accuracy could be improved by establishing novel ACEF-derived risk models.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A total of 1146 patients were included. The study endpoint was 1-year major adverse cardio-cerebrovascular events, including all-cause death, nonfatal myocardial infarction, unplanned revascularization, and nonfatal stroke. Accuracy was defined with area under the curve by receiver-operating characteristic curve analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The incidence of 1-year major adverse cardio-cerebrovascular event increased with the rising age, creatinine, and ejection fraction score tertiles (4.8%, 8.4%, and 15.2%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001 for all). Higher ACEF score was significantly associated with an increased risk of the endpoint in overall (odds ratio = 3.75, 95% confidence interval, 2.44\u20135.77, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) and in subgroups (all <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). The accuracy of the ACEF score was equivalent to the other complex risk scores. The combination of ACEF, and diabetes (ACEF-diabetes score) yielded a superior discriminatory ability than the original ACEF score (increase in C-statistic from 0.67 to 0.71, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.048; continuous net reclassification improvement = 51.9%, 95% confidence interval, 33.4\u201370.5%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001; integrated discrimination improvement = 0.020, 95% confidence interval, 0.011\u20130.030, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The simplified ACEF score performed well in predicting 1-year outcomes in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention. The novel ACEF-diabetes score provided a better predictive value and thus may help stratify high-risk patients and potentially facilitate decision making.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000000791","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T14:43:09Z","timestamp":1567089789000},"page":"109-117","source":"Crossref","is-referenced-by-count":15,"title":["Predictive value of the combination of age, creatinine, and ejection fraction score and diabetes in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention"],"prefix":"10.1097","volume":"31","author":[{"given":"Side","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqiao","family":"Zhao","sequence":"additional","affiliation":[{"name":"Clinical Atherosclerosis Research Lab, Division of Cardiology, University of Washington, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University"},{"name":"Beijing Key Laboratory of Metabolic Disorders Related Cardiovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230924","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"127","author":"O\u2019Gara","year":"2013","journal-title":"Circulation"},{"key":"R2-20230924","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jacc.2015.10.005","article-title":"2015 ACC\/AHA\/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction.","volume":"67","author":"Levine","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R3-20230924","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.jacc.2014.08.037","article-title":"Short- and long-term cause of death in patients treated with primary PCI for STEMI.","volume":"64","author":"Pedersen","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R4-20230924","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1161\/CIRCULATIONAHA.108.842393","article-title":"Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony.","volume":"119","author":"Ranucci","year":"2009","journal-title":"Circulation"},{"key":"R5-20230924","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jtcvs.2010.11.064","article-title":"The easier, the better: age, creatinine, ejection fraction score for operative mortality risk stratification in a series of 29,659 patients undergoing elective cardiac surgery.","volume":"142","author":"Ranucci","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R6-20230924","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/CIRCINTERVENTIONS.110.958389","article-title":"Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the \u2018all-comers\u2019 LEADERS trial.","volume":"4","author":"Wykrzykowska","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"R7-20230924","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"31","author":"Kolh","year":"2010","journal-title":"Eur Heart J"},{"key":"R8-20230924","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for CardioThoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"R9-20230924","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization.","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"R10-20230924","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.38985.646481.55","article-title":"Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE).","volume":"333","author":"Fox","year":"2006","journal-title":"BMJ"},{"key":"R11-20230924","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/01.CIR.102.17.2031","article-title":"TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous npa for treatment of infarcting myocardium early II trial substudy.","volume":"102","author":"Morrow","year":"2000","journal-title":"Circulation"},{"key":"R12-20230924","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","article-title":"A more meaningful scoring system for determining the severity of coronary heart disease.","volume":"51","author":"Gensini","year":"1983","journal-title":"Am J Cardiol"},{"key":"R13-20230924","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018).","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R14-20230924","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jacc.2017.12.048","article-title":"2017 cardiovascular and stroke endpoint definitions for clinical trials.","volume":"71","author":"Hicks","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"R15-20230924","first-page":"S13","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes-2018.","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"R16-20230924","doi-asserted-by":"crossref","first-page":"g4356","DOI":"10.1136\/bmj.g4356","article-title":"Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance.","volume":"349","author":"Rabar","year":"2014","journal-title":"BMJ"},{"key":"R17-20230924","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1002\/sim.5777","article-title":"On use of partial area under the ROC curve for evaluation of diagnostic performance.","volume":"32","author":"Ma","year":"2013","journal-title":"Stat Med"},{"key":"R18-20230924","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"R19-20230924","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"R20-20230924","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"key":"R21-20230924","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/eurheartj\/ehx228","article-title":"The ACEF II risk score for cardiac surgery: updated but still parsimonious.","volume":"39","author":"Ranucci","year":"2018","journal-title":"Eur Heart J"},{"key":"R22-20230924","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.amjcard.2015.02.001","article-title":"Prognostic value of the age, creatinine, and ejection fraction score for 1-year mortality in 30-day survivors who underwent percutaneous coronary intervention after acute myocardial infarction.","volume":"115","author":"Lee","year":"2015","journal-title":"Am J Cardiol"},{"key":"R23-20230924","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2018.05.134","article-title":"Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes.","volume":"270","author":"St\u00e4hli","year":"2018","journal-title":"Int J Cardiol"},{"key":"R24-20230924","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijcard.2018.04.017","article-title":"ACEF score adapted to ST-elevation myocardial infarction patients: the ACEF-STEMI score.","volume":"264","author":"Reindl","year":"2018","journal-title":"Int J Cardiol"},{"key":"R25-20230924","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4244\/EIJV8I3A55","article-title":"Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) score.","volume":"8","author":"Biondi-Zoccai","year":"2012","journal-title":"Eurointervention"},{"key":"R26-20230924","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/ccd.25360","article-title":"ACEF and clinical SYNTAX score in the risk stratification of patients with heavily calcified coronary stenosis undergoing rotational atherectomy with stent implantation.","volume":"83","author":"Pyxaras","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"R27-20230924","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.amjcard.2014.07.034","article-title":"The age, creatinine, and ejection fraction score to risk stratify patients who underwent percutaneous coronary intervention of coronary chronic total occlusion.","volume":"114","author":"Di Serafino","year":"2014","journal-title":"Am J Cardiol"},{"key":"R28-20230924","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.","volume":"360","author":"Serruys","year":"2009","journal-title":"N Engl J Med"},{"key":"R29-20230924","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(13)60108-7","article-title":"Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II.","volume":"381","author":"Farooq","year":"2013","journal-title":"Lancet"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000791","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T07:05:39Z","timestamp":1695539139000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000791","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}